Discontinued — last reported Q4 '24
Vertex Pharmaceuticals State and Local Income Taxes, Net remained flat by 0.0% to -$475.00K in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates higher state-level tax burdens, potentially due to changes in operations or tax laws in specific regions.
Represents the net expense incurred for state and local income taxes after accounting for the federal tax benefit of ded...
Standard line item for US-based companies with significant domestic operations.
is_cat_state_and_local_income_taxes_net| FY'25 | |
|---|---|
| Value | -$1.90M |
We use cookies for analytics. See our Privacy and Cookie Policy.